Moreover, our observations on the receptor‐mediated mode of action of the anthraquinone compound, combined to the strong and widespread expression of SSTR2 in human neuroblastoma specimens and prompt to a further development of AE as a personalized antitumor agent and to explore its potential use for other biological application mediated by somatostatin receptors. This evidence concerns the gene SSTR2 and neuroblastoma.